XML 22 R10.htm IDEA: XBRL DOCUMENT
v3.23.3

ACQUISITIONS | 9 Months Ended
--- | ---
Sep. 30, 2023
ACQUISITIONS |
ACQUISITIONS |
2. | ACQUISITIONS
On July 31, 2023, a subsidiary of the Company, Blast Asset Acquisition LLC, completed its acquisition of substantially all of the assets of Vital Pharmaceuticals, Inc. and its debtor affiliates (collectively, “Bang Energy”) (the “Bang Transaction”). The acquired assets primarily include Bang Energy® drinks and a beverage production facility in Phoenix, AZ. The Company accounted for the Bang Transaction in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 805 “Business Combinations”. Under the acquisition method of accounting, the Company allocated the purchase price of the acquisition to identifiable assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date. During the three-months ended September 30, 2023, in connection with the Bang Transaction, the Company recorded a gain of $45.4 million in interest and other income (expense), net within the condensed consolidated statements of income and reported within the Corporate and Unallocated segment (the "Bang Transaction Gain"). During the three-and nine-months ended September 30, 2023, the Company incurred approximately $8.0 million and $15.1 million, respectively, of acquisition costs related to the Bang Transaction. The following table summarizes the preliminary fair value allocations of the Bang Transaction: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Identifiable | ​ | ​ | ​
​ | ​ | Assets Acquired | ​ | ​ | ​
​ | ​ | and (Liabilities) | ​ | Consideration
​ | ​ | Assumed | ​ | Transferred
Intangibles - trademarks (non-amortizing) | ​ | $ | 209,000 | ​ | $ | —
Intangibles - customer relationships (amortizing) | ​ |  | 23,000 | ​ |  | —
Property and equipment, net | ​ |  | 143,200 | ​ |  | —
Inventory | ​ |  | 30,496 | ​ |  | —
Right-of -use assets | ​ |  | 12,523 | ​ |  | —
Operating lease liabilities | ​ |  | (12,523) | ​ |  | —
Working capital (excluding inventory) | ​ |  | 2,871 | ​ |  | —
Other | ​ |  | 200 | ​ |  | —
Cash | ​ |  | — | ​ |  | 363,385
Bang Transaction Gain | ​ |  | — | ​ |  | 45,382
Total | ​ | $ | 408,767 | ​ | $ | 408,767
​ The fair value analysis has yet to progress to a stage where there is sufficient information for a definitive measurement of the respective fair values. Accordingly, the respective fair value allocations are preliminary and are based on valuations derived from estimated fair value assumptions used by management. The Company expects to complete its fair value analysis at a level of detail necessary to finalize the underlying fair value allocations as soon as practicable, but no later than twelve months from the closing of the Bang Transaction. Any differences between the final respective fair value allocations and the preliminary management estimates may have an impact on the Company’s financial position and results of operations. The Company determined the fair values as follows:
| ● | Trademarks – relief-from-royalty method of the income approach
| ● | Customer relationships – multi-period excess earnings method of the income approach
| ● | Property and equipment – cost approach and market approach
| ● | Inventory – comparative sales method and replacement cost method
| ● | Bang Transaction Gain - residual of net assets acquired less cash consideration transferred
The book value of the working capital (excluding inventory) approximates fair value due to the short-term nature of the accounts. For tax purposes, the Bang Transaction was recorded as an asset purchase. In accordance with Regulation S-X, pro forma unaudited condensed financial information for the Bang Transaction has not been provided as the impact of the transaction on the Company’s financial position, results of operations and liquidity was not material.

X
- Definition The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//805/tableOfContent + Details
Name: | us-gaap_BusinessCombinationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration